1 / 6

Transdermal Drug Delivery System Market 2020 Overview by Key Players Analysis, Emerging Opportunities, Comprehensive Res

The global transdermal drug delivery system (TDDS) market was valued at USD 5,737 million in 2020 and is projected to grow at a CAGR of 4.7% during the forecast period.

MargaretsHill
Télécharger la présentation

Transdermal Drug Delivery System Market 2020 Overview by Key Players Analysis, Emerging Opportunities, Comprehensive Res

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Adroit Market Research Transdermal Drug Delivery System Market Size 2020, By Test (Transdermal Patches, Transdermal Semisolids) Application (Pain Management, Hormonal Applications, Central Nervous System Disorders, Cardiovascular Diseases, Other Applications) Region and Forecast 2021 to 2028 Single Use License: US$ 4400 Request Sample +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  2. Adroit Market Research Global Transdermal Drug Delivery System Market To Grow From USD 5,737 Global Transdermal Drug Delivery System Market To Grow From USD 5,737 Million In 2020 To USD 8,117 Million By 2028 Million In 2020 To USD 8,117 Million By 2028 The global transdermal drug delivery system market is projected to reach USD 8,117 million by 2028, growing at a CAGR of 4.7%. Enhancing bioavailability via bypassing first pass metabolism, improving tolerability and dosing, minimizing pharmaco- kinetic peaks and troughs and increasing patient compliance in continuous delivery are some of the factors driving the growth of the global transdermal drug delivery system (TDDS) market. Adroit Market Research report on global transdermal drug delivery system market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global transdermal drug delivery system market have been studied in detail. Transdermal drug delivery systems offer several important advantages over more traditional approaches, including longer duration of action resulting in a reduction in dosing frequency, increased convenience to administer drugs which would otherwise require frequent dosing, improved bioavailability, more uniform plasma levels, reduced side effects and improved therapy due to maintenance of plasma levels up to the end of the dosing interval, flexibility of terminating the drug administration by simply removing the patch from the skin, improved patient compliance and comfort via non-invasive, painless and simple application. Moreover, itching, and local edema can be caused by the drug, the adhesive, or other excipients in the patch formulation may hinder the market growth. +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  3. Adroit Market Research Global Transdermal Drug Delivery System Market To Grow From USD 5,737 Global Transdermal Drug Delivery System Market To Grow From USD 5,737 Million In 2020 To USD 8,117 Million By 2028 Million In 2020 To USD 8,117 Million By 2028 The global transdermal drug delivery system market is categorized based on type and application. By type, transdermal patch is set to grow at a highest pace due to increased bioavailability. Application wise, the pain management segment is projected to account for the largest market share owing to its raising application in cancer pain management. In 2020, North America was the largest market for transdermal drug delivery system owing to rising prevalence of targeted diseases. Moreover, Asia Pacific is projected to grow at a highest pace during the forecast period. Key players of the global transdermal drug delivery system market include Hisamitsu Pharmaceutical, Novartis, Mylan, UCB, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Endo International, 3M Company and Purdue Pharma among others. Browse the complete report on @ https://www.adroitmarketresearch.com/industry-reports/transdermal-drug- delivery-system-market +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  4. Adroit Market Research Key segments of the global Key segments of the global transdermal drug delivery system transdermal drug delivery systemmarket market Type Overview, 2018-2028 (USD Million) Transdermal Patches Transdermal Semisolids Application Overview, 2018-2028 (USD Million) Pain Management Hormonal Applications Central Nervous System Disorders Cardiovascular Diseases Other Applications +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  5. Adroit Market Research Key segments of the global Key segments of the global transdermal drug delivery system transdermal drug delivery systemmarket market Regional Overview, 2015-2025 (USD million) (Kilo tons) • North America • Europe • Asia Pacific • Central & South America • Middle East & Africa Purchase a single user copy of the global transdermal drug delivery system market report@ https://www.adroitmarketresearch.com/researchreport/purchase/1595 +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  6. Adroit Market Research About Us About Us Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps. Our analysts have tracked high growth markets in chemicals & materials, healthcare & pharmaceuticals, semiconductor & electronics, energy & power, food & retail, consumer goods, technology, and machinery & equipment sectors across the world to identify new opportunities, potential customers, prepare go-to-market (GTM) strategies, identify segments for revenue growth for companies, and manymore. Contact Us US Headquarters Phone: +1 (214) 884-6068 Email: sales@adroitmarketresearch.com 3131 McKinney Ave Ste 600 Dallas, TX 75204 ,U.S.A +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

More Related